Gut dysfunction in Parkinson's disease

World Journal of Gastroenterology

Volumn 22, Issue 25, 2016, Pages 5742-5752

  Mukherjee, Adreesh ^a   Biswas, Atanu ^a   Das, Shyamal Kumar ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Constipation; Dysphagia; Gastroparesis; Gut dysfunction; Gut microbiota; Parkinson's disease; Sialorrhea

Indexed keywords

ALPHA SYNUCLEIN; BIOLOGICAL MARKER; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLYCOPYRRONIUM BROMIDE; ISPAGULA; LEVODOPA; NIZATIDINE; ANTIPARKINSON AGENT;

BACTERIAL OVERGROWTH; CONSTIPATION; DEFECATION DISORDER; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE ASSOCIATION; DYSPHAGIA; ENTEROPATHY; EXERCISE; FLUID INTAKE; HELICOBACTER INFECTION; HIGH FIBER DIET; HUMAN; HYPERSALIVATION; INTESTINE FLORA; LIFESTYLE MODIFICATION; MALNUTRITION; MOUTH DISEASE; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; REVIEW; STOMACH EMPTYING; STOMACH PARESIS; SWALLOWING; SYMPTOM; COMPLICATION; DEGLUTITION DISORDERS; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL TRACT; GASTROPARESIS; INTESTINE INNERVATION; METABOLISM; SIALORRHEA;

ALPHA-SYNUCLEIN; ANTIPARKINSON AGENTS; CONSTIPATION; DEGLUTITION DISORDERS; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; GASTROPARESIS; HUMANS; MALNUTRITION; PARKINSON DISEASE; SIALORRHEA;

EID: 84977635947     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i25.5742     Document Type: Review

References (136)

1. Kalia LV, Lang AE. Parkinson's disease. Lancet 2015; 386: 896-912 [PMID: 25904081 DOI: 10.1016/S0140-6736(14)61393-3]
2. Goldstein DS, Sewell L, Sharabi Y. Autonomic dysfunction in PD: a window to early detection? J Neurol Sci 2011; 310: 118-122 [PMID: 21529844 DOI: 10.1016/j.jns.2011.04.011]
3. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Parkinsonism Relat Disord 2011; 17: 10-15 [PMID: 20829091 DOI: 10.1016/j.parkreldis.2010.08.003]
4. Sung HY, Park JW, Kim JS. The frequency and severity of gastrointestinal symptoms in patients with early Parkinson's disease. J Mov Disord 2014; 7: 7-12 [PMID: 24926404 DOI: 10.14802/ jmd.14002]
5. Del Tredici K, Rüb U, De Vos RA, Bohl JR, Braak H. Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 2002; 61: 413-426 [PMID: 12030260 DOI: 10.1093/ jnen/61.5.413]
6. Ruffmann C, Parkkinen L. Gut Feelings About α-Synuclein in Gastrointestinal Biopsies: Biomarker in the Making? Mov Disord 2016; 31: 193-202 [PMID: 26799450 DOI: 10.1002/mds.26480]
7. Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol 1988; 76: 217-221 [PMID: 2850698 DOI: 10.1007/BF00687767]
8. Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 2010; 119: 689-702 [PMID: 20306269 DOI: 10.1007/ s00401-010-0664-3]
9. Cersosimo MG, Benarroch EE. Pathological correlates of gastrointestinal dysfunction in Parkinson's disease. Neurobiol Dis 2012; 46: 559-564 [PMID: 22048068 DOI: 10.1016/ j.nbd.2011.10.014]
10. Hilton D, Stephens M, Kirk L, Edwards P, Potter R, Zajicek J, Broughton E, Hagan H, Carroll C. Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease. Acta Neuropathol 2014; 127: 235-241 [PMID: 24240814 DOI: 10.1007/s00401-013-1214-6]
11. Gray MT, Munoz DG, Gray DA, Schlossmacher MG, Woulfe JM. Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects. Mov Disord 2014; 29: 991-998 [PMID: 24352892 DOI: 10.1002/mds.25779]
12. Braak H, Rüb U, Gai WP, Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm (Vienna) 2003; 110: 517-536 [PMID: 12721813 DOI: 10.1007/ s00702-002-0808-2]
13. Hawkes CH, Del Tredici K, Braak H. Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 2007; 33: 599-614 [PMID: 17961138 DOI: 10.1111/j.1365-2990.2007.00874.x]
14. Kuo YM, Li Z, Jiao Y, Gaborit N, Pani AK, Orrison BM, Bruneau BG, Giasson BI, Smeyne RJ, Gershon MD, Nussbaum RL. Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum Mol Genet 2010; 19: 1633-1650 [PMID: 20106867 DOI: 10.1093/hmg/ddq038]
15. Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 2008; 14: 504-506 [PMID: 18391962 DOI: 10.1038/nm1747]
16. Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Björklund A, Widner H, Revesz T, Lindvall O, Brundin P. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 2008; 14: 501-503 [PMID: 18391963 DOI: 10.1038/nm1746]
17. Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 2015; 28: 203-209 [PMID: 25830558]
18. Mulak A, Bonaz B. Brain-gut-microbiota axis in Parkinson's disease. World J Gastroenterol 2015; 21: 10609-10620 [PMID: 26457021 DOI: 10.3748/wjg.v21.i37.10609]
19. Rees K, Stowe R, Patel S, Ives N, Breen K, Clarke CE, Ben-Shlomo Y. Helicobacter pylori eradication for Parkinson's disease. Cochrane Database Syst Rev 2011; (11): CD008453 [PMID: 22071847 DOI: 10.1002/14651858.CD008453.pub2]
20. Tan AH, Mahadeva S, Marras C, Thalha AM, Kiew CK, Yeat CM, Ng SW, Ang SP, Chow SK, Loke MF, Vadivelu JS, Ibrahim N, Yong HS, Tan CT, Fox SH, Lang AE, Lim SY. Helicobacter pylori infection is associated with worse severity of Parkinson's disease. Parkinsonism Relat Disord 2015; 21: 221-225 [PMID: 25560322 DOI: 10.1016/j.parkreldis.2014.12.009]
21. Fasano A, Bove F, Gabrielli M, Petracca M, Zocco MA, Ragazzoni E, Barbaro F, Piano C, Fortuna S, Tortora A, Di Giacopo R, Campanale M, Gigante G, Lauritano EC, Navarra P, Marconi S, Gasbarrini A, Bentivoglio AR. The role of small intestinal bacterial overgrowth in Parkinson's disease. Mov Disord 2013; 28: 1241-1249 [PMID: 23712625 DOI: 10.1002/mds.25522]
22. Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, Kinnunen E, Murros K, Auvinen P. Gut microbiota are related to Parkinson' s disease and clinical phenotype. Mov Disord 2015; 30: 350-358 [PMID: 25476529 DOI: 10.1002/mds.26069]
23. Annerino DM, Arshad S, Taylor GM, Adler CH, Beach TG, Greene JG. Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol 2012; 124: 665-680 [PMID: 22941241 DOI: 10.1007/s00401-012-1040-2]
24. Lebouvier T, Chaumette T, Damier P, Coron E, Touchefeu Y, Vrignaud S, Naveilhan P, Galmiche JP, Bruley des Varannes S, Derkinderen P, Neunlist M. Pathological lesions in colonic biopsies during Parkinson's disease. Gut 2008; 57: 1741-1743 [PMID: 19022934 DOI: 10.1136/gut.2008.162503]
25. Muntané G, Ferrer I, Martinez-Vicente M. α-synuclein phosphorylation and truncation are normal events in the adult human brain. Neuroscience 2012; 200: 106-119 [PMID: 22079575 DOI: 10.1016/j.neuroscience.2011.10.042]
26. Visanji NP, Marras C, Hazrati LN, Liu LW, Lang AE. Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker. Mov Disord 2014; 29: 444-450 [PMID: 24375496 DOI: 10.1002/mds.25789]
27. Visanji NP, Marras C, Kern DS, Al Dakheel A, Gao A, Liu LW, Lang AE, Hazrati LN. Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease. Neurology 2015; 84: 609-616 [PMID: 25589666 DOI: 10.1212/WNL.0000000000001240]
28. Beach TG, Adler CH, Dugger BN, Serrano G, Hidalgo J, Henry-Watson J, Shill HA, Sue LI, Sabbagh MN, Akiyama H; Arizona Parkinson's Disease Consortium. Submandibular gland biopsy for the diagnosis of Parkinson disease. J Neuropathol Exp Neurol 2013; 72: 130-136 [PMID: 23334596 DOI: 10.1097/NEN.0b013e3182805c72]
29. Adler CH, Dugger BN, Hinni ML, Lott DG, Driver-Dunckley E, Hidalgo J, Henry-Watson J, Serrano G, Sue LI, Nagel T, Duffy A, Shill HA, Akiyama H, Walker DG, Beach TG. Submandibular gland needle biopsy for the diagnosis of Parkinson disease. Neurology 2014; 82: 858-864 [PMID: 24500652 DOI: 10.1212/ WNL.0000000000000204]
30. van der Marck MA, Dicke HC, Uc EY, Kentin ZH, Borm GF, Bloem BR, Overeem S, Munneke M. Body mass index in Parkinson' s disease: a meta-analysis. Parkinsonism Relat Disord 2012; 18: 263-267 [PMID: 22100523 DOI: 10.1016/j.parkreldis.2011.10.016]
31. Akbar U, He Y, Dai Y, Hack N, Malaty I, McFarland NR, Hess C, Schmidt P, Wu S, Okun MS. Weight loss and impact on quality of life in Parkinson's disease. PLoS One 2015; 10: e0124541 [PMID: 25938478 DOI: 10.1371/journal.pone.0124541]
32. Sheard JM, Ash S, Mellick GD, Silburn PA, Kerr GK. Malnutrition in a sample of community-dwelling people with Parkinson's disease. PLoS One 2013; 8: e53290 [PMID: 23326408 DOI: 10.1371/journal. pone.0053290]
33. Fereshtehnejad SM, Ghazi L, Shafieesabet M, Shahidi GA, Delbari A, Lökk J. Motor, psychiatric and fatigue features associated with nutritional status and its effects on quality of life in Parkinson's disease patients. PLoS One 2014; 9: e91153 [PMID: 24608130 DOI: 10.1371/journal.pone.0091153]
34. Pilhatsch M, Kroemer NB, Schneider C, Ebersbach G, Jost WH, Fuchs G, Odin P, Reifschneider G, Bauer M, Reichmann H, Storch A. Reduced body mass index in Parkinson's disease: contribution of comorbid depression. J Nerv Ment Dis 2013; 201: 76-79 [PMID: 23274301 DOI: 10.1097/NMD.0b013e31827ab2cc]
35. Kim HJ, Oh ES, Lee JH, Moon JS, Oh JE, Shin JW, Lee KJ, Baek IC, Jeong SH, Song HJ, Sohn EH, Lee AY. Relationship between changes of body mass index (BMI) and cognitive decline in Parkinson's disease (PD). Arch Gerontol Geriatr 2012; 55: 70-72 [PMID: 21763014 DOI: 10.1016/j.archger.2011.06.022]
36. Laudisio A, Vetrano DL, Meloni E, Ricciardi D, Franceschi F, Bentivoglio AR, Bernabei R, Zuccalà G. Dopaminergic agents and nutritional status in Parkinson's disease. Mov Disord 2014; 29: 1543-1547 [PMID: 25214286 DOI: 10.1002/mds.25991]
37. Lv Z, Qi H, Wang L, Fan X, Han F, Wang H, Bi S. Vitamin D status and Parkinson's disease: a systematic review and meta-analysis. Neurol Sci 2014; 35: 1723-1730 [PMID: 24847960 DOI: 10.1007/ s10072-014-1821-6]
38. van den Bos F, Speelman AD, Samson M, Munneke M, Bloem BR, Verhaar HJ. Parkinson's disease and osteoporosis. Age Ageing 2013; 42: 156-162 [PMID: 23132148 DOI: 10.1093/ageing/afs161]
39. Morales-Briceño H, Cervantes-Arriaga A, Rodríguez-Violante M, Calleja-Castillo J, Corona T. Overweight is more prevalent in patients with Parkinson's disease. Arq Neuropsiquiatr 2012; 70: 843-846 [PMID: 23175195 DOI: 10.1590/S0004-282X2012001100004]
40. Vikdahl M, Carlsson M, Linder J, Forsgren L, Håglin L. Weight gain and increased central obesity in the early phase of Parkinson' s disease. Clin Nutr 2014; 33: 1132-1139 [PMID: 24423747 DOI: 10.1016/j.clnu.2013.12.012]
41. Nirenberg MJ, Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 2006; 21: 524-529 [PMID: 16261618 DOI: 10.1002/mds.20757]
42. Strowd RE, Herco M, Passmore-Griffin L, Avery B, Haq I, Tatter SB, Tate J, Siddiqui MS. Association between subthalamic nucleus deep brain stimulation and weight gain: Results of a case-control study. Clin Neurol Neurosurg 2016; 140: 38-42 [PMID: 26619034 DOI: 10.1016/j.clineuro.2015.11.002]
43. Hanaoka A, Kashihara K. Increased frequencies of caries, periodontal disease and tooth loss in patients with Parkinson's disease. J Clin Neurosci 2009; 16: 1279-1282 [PMID: 19570683 DOI: 10.1016/j.jocn.2008.12.027]
44. Müller T, Palluch R, Jackowski J. Caries and periodontal disease in patients with Parkinson's disease. Spec Care Dentist 2011; 31: 178-181 [PMID: 21950532 DOI: 10.1111/j.1754-4505.2011.00205.x]
45. Zlotnik Y, Balash Y, Korczyn AD, Giladi N, Gurevich T. Disorders of the oral cavity in Parkinson's disease and parkinsonian syndromes. Parkinsons Dis 2015; 2015: 379482 [PMID: 25685594 DOI: 10.1155/2015/379482]
46. Coon EA, Laughlin RS. Burning mouth syndrome in Parkinson' s disease: dopamine as cure or cause? J Headache Pain 2012; 13: 255-257 [PMID: 22322657 DOI: 10.1007/s10194-012-0421-1]
47. Leibner J, Ramjit A, Sedig L, Dai Y, Wu SS, Jacobson C, Okun MS, Rodriguez RL, Malaty IA, Fernandez HH. The impact of and the factors associated with drooling in Parkinson's disease. Parkinsonism Relat Disord 2010; 16: 475-477 [PMID: 20064737 DOI: 10.1016/j.parkreldis.2009.12.003]
48. Kalf JG, Smit AM, Bloem BR, Zwarts MJ, Munneke M. Impact of drooling in Parkinson's disease. J Neurol 2007; 254: 1227-1232 [PMID: 17671806 DOI: 10.1007/s00415-007-0508-9]
49. Srivanitchapoom P, Pandey S, Hallett M. Drooling in Parkinson' s disease: a review. Parkinsonism Relat Disord 2014; 20: 1109-1118 [PMID: 25200111 DOI: 10.1016/j.parkreldis.2014.08.013]
50. Nóbrega AC, Rodrigues B, Torres AC, Scarpel RD, Neves CA, Melo A. Is drooling secondary to a swallowing disorder in patients with Parkinson's disease? Parkinsonism Relat Disord 2008; 14: 243-245 [PMID: 17892967 DOI: 10.1016/j.parkreldis.2007.08.003]
51. Nicaretta DH, Rosso AL, Mattos JP, Maliska C, Costa MM. Dysphagia and sialorrhea: the relationship to Parkinson's disease. Arq Gastroenterol 2013; 50: 42-49 [PMID: 23657306 DOI: 10.1590/ S0004-28032013000100009]
52. Kalf JG, Munneke M, van den Engel-Hoek L, de Swart BJ, Borm GF, Bloem BR, Zwarts MJ. Pathophysiology of diurnal drooling in Parkinson's disease. Mov Disord 2011; 26: 1670-1676 [PMID: 21484876 DOI: 10.1002/mds.23720]
53. Proulx M, de Courval FP, Wiseman MA, Panisset M. Salivary production in Parkinson's disease. Mov Disord 2005; 20: 204-207 [PMID: 15389996 DOI: 10.1002/mds.20189]
54. Ou R, Guo X, Wei Q, Cao B, Yang J, Song W, Shao N, Zhao B, Chen X, Shang H. Prevalence and clinical correlates of drooling in Parkinson disease: a study on 518 Chinese patients. Parkinsonism Relat Disord 2015; 21: 211-215 [PMID: 25537930 DOI: 10.1016/ j.parkreldis.2014.12.004]
55. Kalf JG, Bloem BR, Munneke M. Diurnal and nocturnal drooling in Parkinson's disease. J Neurol 2012; 259: 119-123 [PMID: 21698387 DOI: 10.1007/s00415-011-6138-2]
56. Ou R, Guo X, Wei Q, Cao B, Yang J, Song W, Chen K, Zhao B, Chen X, Shang H. Diurnal drooling in Chinese patients with Parkinson's disease. J Neurol Sci 2015; 353: 74-78 [PMID: 25896289 DOI: 10.1016/j.jns.2015.04.007]
57. Rana AQ, Khondker S, Kabir A, Owalia A, Khondker S, Emre M. Impact of cognitive dysfunction on drooling in Parkinson' s disease. Eur Neurol 2013; 70: 42-45 [PMID: 23711510 DOI: 10.1159/000348571]
58. Rodrigues B, Nóbrega AC, Sampaio M, Argolo N, Melo A. Silent saliva aspiration in Parkinson's disease. Mov Disord 2011; 26: 138-141 [PMID: 21322025 DOI: 10.1002/mds.23301]
59. Arbouw ME, Movig KL, Koopmann M, Poels PJ, Guchelaar HJ, Egberts TC, Neef C, van Vugt JP. Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial. Neurology 2010; 74: 1203-1207 [PMID: 20385892 DOI: 10.1212/ WNL.0b013e3181d8c1b7]
60. Thomsen TR, Galpern WR, Asante A, Arenovich T, Fox SH. Ipratropium bromide spray as treatment for sialorrhea in Parkinson' s disease. Mov Disord 2007; 22: 2268-2273 [PMID: 17876852 DOI: 10.1002/mds.21730]
61. Lloret SP, Nano G, Carrosella A, Gamzu E, Merello M. A doubleblind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patients. J Neurol Sci 2011; 310: 248-250 [PMID: 21636098 DOI: 10.1016/j.jns.2011.05.021]
62. Petracca M, Guidubaldi A, Ricciardi L, Ialongo T, Del Grande A, Mulas D, Di Stasio E, Bentivoglio AR. Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview. Toxicon 2015; 107: 129-140 [PMID: 26327120 DOI: 10.1016/ j.toxicon.2015.08.014]
63. Egevad G, Petkova VY, Vilholm OJ. Sialorrhea in patients with Parkinson's disease: safety and administration of botulinum neurotoxin. J Parkinsons Dis 2014; 4: 321-326 [PMID: 24919823 DOI: 10.3233/JPD-140379]
64. Postma AG, Heesters M, van Laar T. Radiotherapy to the salivary glands as treatment of sialorrhea in patients with parkinsonism. Mov Disord 2007; 22: 2430-2435 [PMID: 17960826 DOI: 10.1002/ mds.21752]
65. Hawkey NM, Zaorsky NG, Galloway TJ. The role of radiation therapy in the management of sialorrhea: A systematic review. Laryngoscope 2016; 126: 80-85 [PMID: 26152655 DOI: 10.1002/ lary.25444]
66. Carneiro D, das Graças Wanderley de Sales Coriolano M, Belo LR, de Marcos Rabelo AR, Asano AG, Lins OG. Quality of life related to swallowing in Parkinson's disease. Dysphagia 2014; 29: 578-582 [PMID: 24952632 DOI: 10.1007/s00455-014-9548-3]
67. Kalf JG, de Swart BJ, Bloem BR, Munneke M. Prevalence of oropharyngeal dysphagia in Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord 2012; 18: 311-315 [PMID: 22137459 DOI: 10.1016/j.parkreldis.2011.11.006]
68. Suttrup I, Warnecke T. Dysphagia in Parkinson's Disease. Dysphagia 2016; 31: 24-32 [PMID: 26590572 DOI: 10.1007/ s00455-015-9671-9]
69. Kim YH, Oh BM, Jung IY, Lee JC, Lee GJ, Han TR. Spatiotemporal characteristics of swallowing in Parkinson's disease. Laryngoscope 2015; 125: 389-395 [PMID: 25093527 DOI: 10.1002/lary.24869]
70. Suntrup S, Teismann I, Bejer J, Suttrup I, Winkels M, Mehler D, Pantev C, Dziewas R, Warnecke T. Evidence for adaptive cortical changes in swallowing in Parkinson's disease. Brain 2013; 136: 726-738 [PMID: 23412935 DOI: 10.1093/brain/awt004]
71. Kikuchi A, Baba T, Hasegawa T, Kobayashi M, Sugeno N, Konno M, Miura E, Hosokai Y, Ishioka T, Nishio Y, Hirayama K, Suzuki K, Aoki M, Takahashi S, Fukuda H, Itoyama Y, Mori E, Takeda A. Hypometabolism in the supplementary and anterior cingulate cortices is related to dysphagia in Parkinson's disease: a crosssectional and 3-year longitudinal cohort study. BMJ Open 2013; 3: [PMID: 23457325 DOI: 10.1136/bmjopen-2012-002249]
72. Lee KD, Koo JH, Song SH, Jo KD, Lee MK, Jang W. Central cholinergic dysfunction could be associated with oropharyngeal dysphagia in early Parkinson's disease. J Neural Transm (Vienna) 2015; 122: 1553-1561 [PMID: 26199040 DOI: 10.1007/s00702- 015-1427-z]
73. Mu L, Sobotka S, Chen J, Su H, Sanders I, Adler CH, Shill HA, Caviness JN, Samanta JE, Beach TG; Arizona Parkinson's Disease Consortium. Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease. J Neuropathol Exp Neurol 2013; 72: 119-129 [PMID: 23334595 DOI: 10.1097/NEN.0b013e3182801cde]
74. Mu L, Sobotka S, Chen J, Su H, Sanders I, Nyirenda T, Adler CH, Shill HA, Caviness JN, Samanta JE, Sue LI, Beach TG; Arizona Parkinson's Disease Consortium. Parkinson disease affects peripheral sensory nerves in the pharynx. J Neuropathol Exp Neurol 2013; 72: 614-623 [PMID: 23771215 DOI: 10.1097/NEN.0b013e3182965886]
75. Cereda E, Cilia R, Klersy C, Canesi M, Zecchinelli AL, Mariani CB, Tesei S, Sacilotto G, Meucci N, Zini M, Isaias IU, Cassani E, Goldwurm S, Barichella M, Pezzoli G. Swallowing disturbances in Parkinson's disease: a multivariate analysis of contributing factors. Parkinsonism Relat Disord 2014; 20: 1382-1387 [PMID: 25456827 DOI: 10.1016/j.parkreldis.2014.09.031]
76. Han M, Ohnishi H, Nonaka M, Yamauchi R, Hozuki T, Hayashi T, Saitoh M, Hisahara S, Imai T, Shimohama S, Mori M. Relationship between dysphagia and depressive states in patients with Parkinson' s disease. Parkinsonism Relat Disord 2011; 17: 437-439 [PMID: 21458355 DOI: 10.1016/j.parkreldis.2011.03.006]
77. Kim JS, Youn J, Suh MK, Kim TE, Chin J, Park S, Cho JW. Cognitive and Motor Aspects of Parkinson's Disease Associated with Dysphagia. Can J Neurol Sci 2015; 42: 395-400 [PMID: 26551089 DOI: 10.1017/cjn.2015.304]
78. Jones CA, Ciucci MR. Multimodal Swallowing Evaluation with High-Resolution Manometry Reveals Subtle Swallowing Changes in Early and Mid-Stage Parkinson Disease. J Parkinsons Dis 2016; 6: 197-208 [PMID: 26891176]
79. Sung HY, Kim JS, Lee KS, Kim YI, Song IU, Chung SW, Yang DW, Cho YK, Park JM, Lee IS, Kim SW, Chung IS, Choi MG. The prevalence and patterns of pharyngoesophageal dysmotility in patients with early stage Parkinson's disease. Mov Disord 2010; 25: 2361-2368 [PMID: 20669313 DOI: 10.1002/mds.23290]
80. Speyer R. Oropharyngeal dysphagia: screening and assessment. Otolaryngol Clin North Am 2013; 46: 989-1008 [PMID: 24262955 DOI: 10.1016/j.otc.2013.08.004]
81. Correa-Flores M, Arch-Tirado E, Villeda-Miranda A, Rocha-Cacho KE, Verduzco-Mendoza A, Hernández-López X. Analysis of oropharyngeal dysphagia through fibroendoscopy evaluation of swallowing in patients with Parkinson's disease. Cir Cir 2012; 80: 31-37 [PMID: 22472150]
82. Argolo N, Sampaio M, Pinho P, Melo A, Nóbrega AC. Videofluoroscopic Predictors of Penetration-Aspiration in Parkinson' s Disease Patients. Dysphagia 2015; 30: 751-758 [PMID: 26492880 DOI: 10.1007/s00455-015-9653-y]
83. Ellerston JK, Heller AC, Houtz DR, Kendall KA. Quantitative Measures of Swallowing Deficits in Patients With Parkinson's Disease. Ann Otol Rhinol Laryngol 2016; 125: 385-392 [PMID: 26602905]
84. Troche MS, Brandimore AE, Okun MS, Davenport PW, Hegland KW. Decreased cough sensitivity and aspiration in Parkinson disease. Chest 2014; 146: 1294-1299 [PMID: 24968148 DOI: 10.1378/chest.14-0066]
85. Lin CW, Chang YC, Chen WS, Chang K, Chang HY, Wang TG. Prolonged swallowing time in dysphagic Parkinsonism patients with aspiration pneumonia. Arch Phys Med Rehabil 2012; 93: 2080-2084 [PMID: 22846454 DOI: 10.1016/j.apmr.2012.07.010]
86. Luchesi KF, Kitamura S, Mourão LF. Dysphagia progression and swallowing management in Parkinson's disease: an observational study. Braz J Otorhinolaryngol 2015; 81: 24-30 [PMID: 25450106 DOI: 10.1016/j.bjorl.2014.09.006]
87. Heijnen BJ, Speyer R, Baijens LW, Bogaardt HC. Neuromuscular electrical stimulation versus traditional therapy in patients with Parkinson's disease and oropharyngeal dysphagia: effects on quality of life. Dysphagia 2012; 27: 336-345 [PMID: 22081122 DOI: 10.1007/s00455-011-9371-z]
88. van Hooren MR, Baijens LW, Voskuilen S, Oosterloo M, Kremer B. Treatment effects for dysphagia in Parkinson's disease: a systematic review. Parkinsonism Relat Disord 2014; 20: 800-807 [PMID: 24794097 DOI: 10.1016/j.parkreldis.2014.03.026]
89. Melo A, Monteiro L. Swallowing improvement after levodopa treatment in idiopathic Parkinson's disease: lack of evidence. Parkinsonism Relat Disord 2013; 19: 279-281 [PMID: 23231973 DOI: 10.1016/j.parkreldis.2012.11.017]
90. Sutton JP. Dysphagia in Parkinson's disease is responsive to levodopa. Parkinsonism Relat Disord 2013; 19: 282-284 [PMID: 23333537 DOI: 10.1016/j.parkreldis.2012.11.007]
91. Hirano M, Isono C, Sakamoto H, Ueno S, Kusunoki S, Nakamura Y. Rotigotine Transdermal Patch Improves Swallowing in Dysphagic Patients with Parkinson's Disease. Dysphagia 2015; 30: 452-456 [PMID: 25966655 DOI: 10.1007/s00455-015-9622-5]
92. Troche MS, Brandimore AE, Foote KD, Okun MS. Swallowing and deep brain stimulation in Parkinson's disease: a systematic review. Parkinsonism Relat Disord 2013; 19: 783-788 [PMID: 23726461 DOI: 10.1016/j.parkreldis.2013.05.001]
93. Troche MS, Brandimore AE, Foote KD, Morishita T, Chen D, Hegland KW, Okun MS. Swallowing outcomes following unilateral STN vs. GPi surgery: a retrospective analysis. Dysphagia 2014; 29: 425-431 [PMID: 24652582 DOI: 10.1007/s00455-014-9522-0]
94. Tanaka Y, Kato T, Nishida H, Yamada M, Koumura A, Sakurai T, Hayashi Y, Kimura A, Hozumi I, Araki H, Murase M, Nagaki M, Moriwaki H, Inuzuka T. Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson's disease? An analysis using the 13C-acetate breath test. J Neurol 2011; 258: 421-426 [PMID: 20938781 DOI: 10.1007/s00415-010-5769-z]
95. Marrinan S, Emmanuel AV, Burn DJ. Delayed gastric emptying in Parkinson's disease. Mov Disord 2014; 29: 23-32 [PMID: 24151126 DOI: 10.1002/mds.25708]
96. Heetun ZS, Quigley EM. Gastroparesis and Parkinson's disease: a systematic review. Parkinsonism Relat Disord 2012; 18: 433-440 [PMID: 22209346 DOI: 10.1016/j.parkreldis.2011.12.004]
97. Goetze O, Nikodem AB, Wiezcorek J, Banasch M, Przuntek H, Mueller T, Schmidt WE, Woitalla D. Predictors of gastric emptying in Parkinson's disease. Neurogastroenterol Motil 2006; 18: 369-375 [PMID: 16629864 DOI: 10.1111/j.1365-2982.2006.00780.x]
98. Pasricha PJ, Parkman HP. Gastroparesis: definitions and diagnosis. Gastroenterol Clin North Am 2015; 44: 1-7 [PMID: 25667018 DOI: 10.1016/j.gtc.2014.11.001]
99. Goetze O, Wieczorek J, Mueller T, Przuntek H, Schmidt WE, Woitalla D. Impaired gastric emptying of a solid test meal in patients with Parkinson's disease using 13C-sodium octanoate breath test. Neurosci Lett 2005; 375: 170-173 [PMID: 15694254 DOI: 10.1016/j.neulet.2004.11.007]
100. Unger MM, Hattemer K, Möller JC, Schmittinger K, Mankel K, Eggert K, Strauch K, Tebbe JJ, Keil B, Oertel WH, Heverhagen JT, Knake S. Real-time visualization of altered gastric motility by magnetic resonance imaging in patients with Parkinson's disease. Mov Disord 2010; 25: 623-628 [PMID: 20213819 DOI: 10.1002/ mds.22841]
101. Naftali T, Gadoth N, Huberman M, Novis B. Electrogastrography in patients with Parkinson's disease. Can J Neurol Sci 2005; 32: 82-86 [PMID: 15825551 DOI: 10.1017/S0317167100016929]
102. Müller T, Erdmann C, Bremen D, Schmidt WE, Muhlack S, Woitalla D, Goetze O. Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients. Clin Neuropharmacol 2006; 29: 61-67 [PMID: 16614536 DOI: 10.1097/ 00002826-200603000-00001]
103. Doi H, Sakakibara R, Sato M, Masaka T, Kishi M, Tateno A, Tateno F, Tsuyusaki Y, Takahashi O. Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease. J Neurol Sci 2012; 319: 86-88 [PMID: 22632782 DOI: 10.1016/j.jns.2012.05.010]
104. Soykan I, Sarosiek I, Shifflett J, Wooten GF, McCallum RW. Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease. Mov Disord 1997; 12: 952-957 [PMID: 9399220 DOI: 10.1002/ mds.870120618]
105. Rossi M, Giorgi G. Domperidone and long QT syndrome. Curr Drug Saf 2010; 5: 257-262 [PMID: 20394569 DOI: 10.2174/157488 610791698334]
106. Doi H, Sakakibara R, Sato M, Hirai S, Masaka T, Kishi M, Tsuyusaki Y, Tateno A, Tateno F, Takahashi O, Ogata T. Nizatidine ameliorates gastroparesis in Parkinson's disease: a pilot study. Mov Disord 2014; 29: 562-566 [PMID: 24375669 DOI: 10.1002/ mds.25777]
107. Karasawa H, Pietra C, Giuliano C, Garcia-Rubio S, Xu X, Yakabi S, Taché Y, Wang L. New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease. Neurogastroenterol Motil 2014; 26: 1771-1782 [PMID: 25327342 DOI: 10.1111/nmo.12459]
108. Kwon KY, Jo KD, Lee MK, Oh M, Kim EN, Park J, Kim JS, Youn J, Oh E, Kim HT, Oh MY, Jang W. Low Serum Vitamin D Levels May Contribute to Gastric Dysmotility in de novo Parkinson's Disease. Neurodegener Dis 2016; 16: 199-205 [PMID: 26735311]
109. Gil RA, Hwynn N, Fabian T, Joseph S, Fernandez HH. Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients. Parkinsonism Relat Disord 2011; 17: 285-287 [PMID: 21296606 DOI: 10.1016/j.parkreldis.2011.01.007]
110. Arai E, Arai M, Uchiyama T, Higuchi Y, Aoyagi K, Yamanaka Y, Yamamoto T, Nagano O, Shiina A, Maruoka D, Matsumura T, Nakagawa T, Katsuno T, Imazeki F, Saeki N, Kuwabara S, Yokosuka O. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease. Brain 2012; 135: 1478-1485 [PMID: 22522940 DOI: 10.1093/brain/aws086]
111. Soffer EE. Gastric electrical stimulation for gastroparesis. J Neurogastroenterol Motil 2012; 18: 131-137 [PMID: 22523722 DOI: 10.5056/jnm.2012.18.2.131]
112. Ondo WG, Shinawi L, Moore S. Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/ levodopa: A single-dose, double-blind, double-dummy, placebocontrolled, crossover trial. Mov Disord 2010; 25: 2724-2727 [PMID: 20925074 DOI: 10.1002/mds.23158]
113. Stocchi F, Zappia M, Dall'Armi V, Kulisevsky J, Lamberti P, Obeso JA; Melevodopa Plus Carbidopa Study Group. Melevodopa/ carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease. Mov Disord 2010; 25: 1881-1887 [PMID: 20669296 DOI: 10.1002/mds.23206]
114. Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH, Vanagunas A, Othman AA, Widnell KL, Robieson WZ, Pritchett Y, Chatamra K, Benesh J, Lenz RA, Antonini A. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol 2014; 13: 141-149 [PMID: 24361112 DOI: 10.1016/S1474- 4422(13)70293-X]
115. Trenkwalder C, Chaudhuri KR, García Ruiz PJ, LeWitt P, Katzenschlager R, Sixel-Döring F, Henriksen T, Sesar Á, Poewe W, Baker M, Ceballos-Baumann A, Deuschl G, Drapier S, Ebersbach G, Evans A, Fernandez H, Isaacson S, van Laar T, Lees A, Lewis S, Martínez Castrillo JC, Martinez-Martin P, Odin P, O'Sullivan J, Tagaris G, Wenzel K; Expert Consensus Group for Use of Apomorphine in Parkinson's Disease. Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson' s disease-Clinical practice recommendations. Parkinsonism Relat Disord 2015; 21: 1023-1030 [PMID: 26189414 DOI: 10.1016/j.park reldis.2015.06.012]
116. Liu Y, Li W, Tan C, Liu X, Wang X, Gui Y, Qin L, Deng F, Hu C, Chen L. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease. J Neurosurg 2014; 121: 709-718 [PMID: 24905564 DOI: 10.3171/2014.4.JNS131711]
117. Miftahussurur M, Yamaoka Y. Diagnostic Methods of Helicobacter pylori Infection for Epidemiological Studies: Critical Importance of Indirect Test Validation. Biomed Res Int 2016; 2016: 4819423 [PMID: 26904678 DOI: 10.1155/2016/4819423]
118. Gabrielli M, D'Angelo G, Di Rienzo T, Scarpellini E, Ojetti V. Diagnosis of small intestinal bacterial overgrowth in the clinical practice. Eur Rev Med Pharmacol Sci 2013; 17 Suppl 2: 30-35 [PMID: 24443065]
119. Jost WH. Gastrointestinal dysfunction in Parkinson's Disease. J Neurol Sci 2010; 289: 69-73 [PMID: 19717168 DOI: 10.1016/ j.jns.2009.08.020]
120. Bassotti G, Maggio D, Battaglia E, Giulietti O, Spinozzi F, Reboldi G, Serra AM, Emanuelli G, Chiarioni G. Manometric investigation of anorectal function in early and late stage Parkinson's disease. J Neurol Neurosurg Psychiatry 2000; 68: 768-770 [PMID: 10811703 DOI: 10.1136/jnnp.68.6.768]
121. Savica R, Carlin JM, Grossardt BR, Bower JH, Ahlskog JE, Maraganore DM, Bharucha AE, Rocca WA. Medical records documentation of constipation preceding Parkinson disease: A casecontrol study. Neurology 2009; 73: 1752-1758 [PMID: 19933976 DOI: 10.1212/WNL.0b013e3181c34af5]
122. Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001; 57: 456-462 [PMID: 11502913 DOI: 10.1212/ WNL.57.3.456]
123. Lin CH, Lin JW, Liu YC, Chang CH, Wu RM. Risk of Parkinson' s disease following severe constipation: a nationwide populationbased cohort study. Parkinsonism Relat Disord 2014; 20: 1371-1375 [PMID: 25293395 DOI: 10.1016/j.parkreldis.2014.09.026]
124. Jost WH, Schrank B. Defecatory disorders in de novo Parkinsonians-colonic transit and electromyogram of the external anal sphincter. Wien Klin Wochenschr 1998; 110: 535-537 [PMID: 9782572]
125. Mathers SE, Kempster PA, Swash M, Lees AJ. Constipation and paradoxical puborectalis contraction in anismus and Parkinson' s disease: a dystonic phenomenon? J Neurol Neurosurg Psychiatry 1988; 51: 1503-1507 [PMID: 3221217 DOI: 10.1136/ jnnp.51.12.1503]
126. Pagano G, Tan EE, Haider JM, Bautista A, Tagliati M. Constipation is reduced by beta-blockers and increased by dopaminergic medications in Parkinson's disease. Parkinsonism Relat Disord 2015; 21: 120-125 [PMID: 25483722 DOI: 10.1016/j.parkreldis.201 4.11.015]
127. Tateno F, Sakakibara R, Yokoi Y, Kishi M, Ogawa E, Uchiyama T, Yamamoto T, Yamanishi T, Takahashi O. Levodopa ameliorated anorectal constipation in de novo Parkinson's disease: The QLGAT study. Parkinsonism Relat Disord 2011; 17: 662-666 [PMID: 21705259 DOI: 10.1016/j.parkreldis.2011.06.002]
128. Sakakibara R, Odaka T, Uchiyama T, Asahina M, Yamaguchi K, Yamaguchi T, Yamanishi T, Hattori T. Colonic transit time and rectoanal videomanometry in Parkinson's disease. J Neurol Neurosurg Psychiatry 2003; 74: 268-272 [PMID: 12531969 DOI: 10.1136/jnnp.74.2.268]
129. Krogh K, Christensen P. Neurogenic colorectal and pelvic floor dysfunction. Best Pract Res Clin Gastroenterol 2009; 23: 531-543 [PMID: 19647688 DOI: 10.1016/j.bpg.2009.04.012]
130. Bharucha AE, Dorn SD, Lembo A, Pressman A. American Gastroenterological Association medical position statement on constipation. Gastroenterology 2013; 144: 211-217 [PMID: 23261064 DOI: 10.1053/j.gastro.2012.10.029]
131. Zangaglia R, Martignoni E, Glorioso M, Ossola M, Riboldazzi G, Calandrella D, Brunetti G, Pacchetti C. Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study. Mov Disord 2007; 22: 1239-1244 [PMID: 17566120 DOI: 10.1002/mds.21243]
132. Ondo WG, Kenney C, Sullivan K, Davidson A, Hunter C, Jahan I, McCombs A, Miller A, Zesiewicz TA. Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease. Neurology 2012; 78: 1650-1654 [PMID: 22573627 DOI: 10.1212/ WNL.0b013e3182574f28]
133. Sakakibara R, Doi H, Sato M, Hirai S, Masaka T, Kishi M, Tsuyusaki Y, Tateno A, Tateno F, Aiba Y, Ogata T, Suzuki Y. Nizatidine ameliorates slow transit constipation in Parkinson's disease. J Am Geriatr Soc 2015; 63: 399-401 [PMID: 25688620 DOI: 10.1111/jgs.13279]
134. Rossi M, Merello M, Perez-Lloret S. Management of constipation in Parkinson's disease. Expert Opin Pharmacother 2015; 16: 547-557 [PMID: 25539892 DOI: 10.1517/14656566.2015.997211]
135. Stern T, Davis AM. Evaluation and Treatment of Patients With Constipation. JAMA 2016; 315: 192-193 [PMID: 26757468 DOI: 10.1001/jama.2015.16995]
136. Cadeddu F, Bentivoglio AR, Brandara F, Marniga G, Brisinda G, Maria G. Outlet type constipation in Parkinson's disease: results of botulinum toxin treatment. Aliment Pharmacol Ther 2005; 22: 997-1003 [PMID: 16268975 DOI: 10.1111/j.1365-2036.2005.02669.x]